Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118422) titled 'Efficacy and safety of Ivarmacitinib in patients with active ankylosing spondylitis:A prospective, multicenter real world study' on Feb. 5.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanghai Changzheng Hospital
Condition:
Ankylosing Spondylitis
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-03-01
Target Sample Size: Test group :500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301467
Published by HT Digital Content Services with permission from Health Daily Digest....